Blood Pressure Medication Guidelines
For adults with confirmed hypertension ≥130/80 mmHg, initiate pharmacologic therapy alongside lifestyle modifications, using first-line agents (ACE inhibitors/ARBs, thiazide-type diuretics, or calcium channel blockers) with specific choices guided by comorbidities and race. 1, 2, 3
Blood Pressure Thresholds for Treatment
Initiate pharmacologic therapy at:
≥130/80 mmHg for patients with:
≥140/90 mmHg for lower-risk patients (10-year ASCVD risk <10%) 4, 2, 3
≥160/100 mmHg: Requires prompt initiation of two drugs from different classes 1, 2
Target Blood Pressure Goals
Target BP <130/80 mmHg for:
- Patients with diabetes 1, 4
- Chronic kidney disease 4, 2
- Clinical cardiovascular disease 4, 2
- Most adults with hypertension 2, 3
First-Line Drug Selection
For Patients WITH Diabetes:
ACE inhibitors or ARBs are first-line when:
- Albuminuria present (UACR ≥30 mg/g) 1
- Coronary artery disease present 1
- Chronic kidney disease present 1, 4
Any first-line agent acceptable (ACE inhibitor, ARB, thiazide-type diuretic, or dihydropyridine CCB) when:
- No albuminuria and no CKD 1
For Patients WITH Chronic Kidney Disease:
ACE inhibitors or ARBs are strongly recommended to improve kidney outcomes 4, 2, 5
Continue these medications even as eGFR declines to <30 mL/min/1.73 m² for cardiovascular benefit 1
For Black Patients:
Thiazide-type diuretics or calcium channel blockers are preferred as initial therapy, even in those with diabetes 2, 6
- ACE inhibitors are less effective for BP lowering and stroke prevention in Black patients 2, 7
- Higher risk of angioedema with ACE inhibitors 2
For General Population (Non-Black, No Diabetes/CKD):
Choose from four first-line classes 2, 7, 3:
- Thiazide-type diuretics (chlorthalidone or indapamide preferred over hydrochlorothiazide) 1, 7
- Long-acting dihydropyridine calcium channel blockers
- ACE inhibitors
- ARBs
Thiazide-type diuretics have superior evidence for preventing heart failure compared to other classes 8, 7
For Patients WITH Heart Failure:
β-blockers are indicated for:
Initial Monotherapy vs. Combination Therapy
Start with TWO drugs when:
Start with ONE drug when:
Use caution with dual therapy initiation in:
Titration Strategy
If target not achieved with single agent: Add second drug from different first-line class 1, 2
Resistant hypertension (not controlled on three drugs including diuretic):
Specific Drug Combinations
Preferred combinations:
- ACE inhibitor + dihydropyridine CCB (superior to ACE inhibitor + hydrochlorothiazide in diabetes) 9
- Thiazide-type diuretic + CCB 6
- ARB + CCB 6
AVOID:
- ACE inhibitor + ARB + renin inhibitor (increased harm without benefit) 9, 3
- ACE inhibitor + ARB in non-proteinuric CKD 9
Common Pitfalls
Do not use β-blockers as first-line unless compelling indication (prior MI, angina, HFrEF), as they are less effective for stroke prevention 1, 7
Do not use α-blockers as first-line in diabetes—less effective than other agents 10
Confirm diagnosis before treatment in low-risk patients to exclude white coat hypertension 4, 11
Monitor monthly until BP control achieved, then reassess adherence and adverse effects regularly 4, 2
For thiazide diuretics: Use chlorthalidone 12.5-25 mg or indapamide rather than hydrochlorothiazide when possible, as longer-acting agents have superior cardiovascular event reduction 1, 2